Immuneering Corporation Earnings Per Share (Basic)
Immuneering Corporation (IMRX) reported Earnings Per Share (Basic) of -$0.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- Immuneering Corporation earnings per share, basic for the quarter ending 2026-06-30 was -$0.27.
- Immuneering Corporation earnings per share, basic for the quarter ending 2026-03-31 was -$0.21.
- Immuneering Corporation earnings per share, basic for the quarter ending 2025-12-31 was -$0.18.
- Immuneering Corporation earnings per share, basic for the quarter ending 2025-09-30 was -$0.38.
- Immuneering Corporation earnings per share, basic for fiscal 2025 was -$1.27.
- Immuneering Corporation earnings per share, basic for fiscal 2024 was -$2.04.
- Immuneering Corporation earnings per share, basic for fiscal 2023 was -$1.88.
- Immuneering Corporation earnings per share, basic for fiscal 2022 was -$1.91.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.27 10-Q · filed 2026-08-05 | -$0.48 10-Q · filed 2026-08-05 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.27 10-K · filed 2026-03-06 |
| 2025-09-30 | -$0.38 10-Q · filed 2025-11-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.20 10-Q · filed 2025-11-12 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$0.40 10-Q · filed 2026-08-05 | -$0.82 10-Q · filed 2026-08-05 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$0.42 10-Q · filed 2026-05-15 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.96 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$2.04 10-K · filed 2026-03-06 |
| 2024-09-30 | -$0.49 10-Q · filed 2025-11-12 | -$0.96 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.45 10-Q · filed 2025-11-12 | -$1.97 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.47 10-Q · filed 2025-08-13 | -$0.96 10-Q · filed 2025-08-13 | -$1.48 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.91 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-03-31 | -$0.49 10-Q · filed 2025-05-05 | -$1.00 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.43 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.86 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2023-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$0.95 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$1.88 10-K · filed 2025-03-20 |
| 2023-09-30 | -$0.43 10-Q · filed 2024-11-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.36 10-Q · filed 2024-11-13 | -$1.86 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-06-30 | -$0.43 10-Q · filed 2024-08-06 | -$0.94 10-Q · filed 2024-08-06 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.92 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-03-31 | -$0.51 10-Q · filed 2024-05-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$1.94 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2022-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$1.43 derived: net income ÷ weighted average shares · filed 2024-03-01 | -$1.91 10-K · filed 2024-03-01 |
| 2022-09-30 | -$0.49 10-Q · filed 2023-11-09 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.41 10-Q · filed 2023-11-09 | -$1.83 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.44 10-Q · filed 2023-08-03 | -$0.93 10-Q · filed 2023-08-03 | -$1.34 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.80 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-04 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.12 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.66 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$2.46 10-K · filed 2023-03-06 |
| 2021-09-30 | -$0.47 10-Q · filed 2022-11-10 | -$1.42 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.41 10-Q · filed 2022-11-10 | -$3.45 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$1.61 10-Q · filed 2022-08-10 | -$2.87 10-Q · filed 2022-08-10 | -$4.05 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$4.94 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-03-31 | -$1.26 10-Q · filed 2022-05-10 | -$2.44 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$3.33 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$4.05 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2020-12-31 | -$1.18 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$2.07 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$2.80 derived: net income ÷ weighted average shares · filed 2022-03-10 | -$3.44 10-K · filed 2022-03-10 |
| 2020-09-30 | -$0.89 10-Q · filed 2021-11-09 | -$1.62 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$2.26 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.73 10-Q · filed 2021-09-09 | -$1.37 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |